from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1380/pyrB

LFCtreatmentdescriptionclass of inhibitor

0.387

Amikacinug/mL Amikacintranslation

0.768

Cap5-10ug/mL Capreomycintranslation

0.492

Rox10-50 ug/mL Roxithromycintranslation

0.606

SM2-5 ug/mL Streptomycintranslation

0.894

Tet5-10 ug/mL Tetracyclinetranslation

0.198

Rif0.2-5ug/mL Rifampicintranscription

0.150

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.262

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.562

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.585

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.314

Clofazimine10-13 ug/mL Clofaziminerespiration

0.441

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.595

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.100

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.323

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.114

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.214

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.134

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.300

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.039

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.029

KCN5-20 ug/mL Potassium cyaniderespiration

-0.192

NaN30.2-2 mM Sodium aziderespiration

-1.394

Nigericin50 uM Nigericinrespiration

-0.127

TRC10-150 ug/mL Triclosanrespiration

-2.076

TRZ10-25 ug/mL Thioridazinerespiration

-1.882

Valinomycin0.5-10 uM Valinomycinrespiration

-0.783

ZnSO42 mM ZnSO4respiration

-0.416

menadione6-10 ug/mL Menadionerespiration

0.677

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.056

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.388

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.797

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.002

NRP_1Non-replicating persistence stage 1dosRassociated

0.032

Amp0.2mg/mL AmpicillincellWall

-0.725

Cephalexin20-100 ug/mL CephalexincellWall

0.533

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.456

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.271

EMB10-20 ug/mL EthambutolcellWall

0.390

Eta12-40 ug/mL EthionamidecellWall

0.585

INH0.2-0.4 ug/mL IsoniazidcellWall

0.153

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.783

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.106

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.224

BZA0.12 mg/mL BenzamidearomaticAmides

0.076

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.353

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.258

H2O24 mM hydrogen peroxideDNAdamaging

0.715

Levo10 ug/mL LevofloxacinDNAdamaging

0.545

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.903

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.225

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.505

UVUV-irradiationDNAdamaging

-0.457

ARP41-4 ug/mL Antitubercular compound ARP4?

0.728

Antimycin12.5-50 ug/mL Antimycin A?

-1.852

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.513

PA_110-50 ug/mL Antitubercular compound PA-1?

0.761

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.127

PA8240.2-2 ug/mL PA-824?

0.592

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.771

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-2.177

Verapamil50 uM Verapamil?

-1.512

mercaptoethanol2 mM 2-Mercaptoethanol?

-2.537

methoxatin10-20 ug/mL Methoxatin?